A small cell ALCL variant presented in a nearly identical manner to the more common ALK+ ALCL, except that it is more frequently associated with leukemic involvement and pursues an aggressive clinical course.[12–14] There is no clear consensus for the treatment of relapse. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.